EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitLeitlinieOpen Access · CC BY-NC-ND 4.0

Summary of the Clinical Practice Guidelines for Upper Tract Urothelial Carcinoma 2023 by the Japanese Urological Association

Kazuyuki Mori, Shingo Hatakeyama iD, Hideki Enokida, Hideaki Miyake, Eiji Kikuchi iD, Hiroyuki Nishiyama, Tomohiko Ichikawa, Takao Kamai iD, Yasushi Kaji, Haruki Kume, Tsunenori Kondo, Hideyasu Matsuyama und 9 weitere

International Journal of Urology · 2024-03 · 31 (3) · 194-207

DOI: 10.1111/iju.15362 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Urology, online erschienen am 19.12.2023. Verfasst von Kazuyuki Mori und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Hirosaki University Graduate School of Medicine, Hirosaki, Aomori, Japan. Hauptthemen laut MEDLINE: Carcinoma, Transitional Cell, Urinary Bladder Neoplasms. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This article is an English translation of the Clinical Practice Guidelines for Upper Tract Urothelial Carcinoma (2nd edition) published in June 2023. The Japanese Urological Association's (JUA) Guidelines Committee on Upper Tract Urothelial Carcinoma (UTUC) created a 2023 update guideline to support clinicians' current evidence‐based management of UTUC and to incorporate its recommendations into clinical practice. The new guideline adhered as closely as possible to the Minds Manual for Guideline Development 2020 ver. 3.0. Findings related to epidemiological, pathological, diagnosis, treatment, and follow‐up were reviewed. In addition, seven clinical questions (CQs) were set to determine the grade of recommendation and level of evidence. Preconceptions and biases were removed from the preparation process, the overall evidence was evaluated appropriately, and recommendations were made after fully considering the balance between benefits and harms. Although the evidence is still insufficient to be taken up as a CQ, the latest important information is described in seven columns, and clinical issues that should be resolved in the future related to the CQ are described as recommendations for tomorrow. We hope that these guidelines will help medical professionals, patients, and their families involved in the treatment of UTUC in their decision‐making, and hope that a critical review of these guidelines will lead to further refinements in the next edition.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Transitional CellUrinary Bladder NeoplasmsHumansJapan

Stichwörter der Autor:innen

clinical practice guidelinediagnosisevidence-based medicinetreatmentupper tract urothelial carcinoma

Autor:innen und Institutionen

  • Department of Urology, Hirosaki University Graduate School of Medicine, Hirosaki, Aomori, Japan.
  • Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Kagoshima, Japan.
  • Department of Urology, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan.
  • Department of Urology, St. Marianna University School of Medicine, Kawasaki, Kanagawa, Japan.
  • Department of Urology, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.
  • Department of Urology, Graduate School of Medicine, Chiba University, Chiba, Chiba, Japan.

ORCID-Profile: Shingo Hatakeyama, Eiji Kikuchi, Takao Kamai, Naoya Masumori, Hirotsugu Uemura, Yasuhisa Fujii

Zitieren

APA

Mori, K., Hatakeyama, S., Enokida, H., Miyake, H., Kikuchi, E., Nishiyama, H., Ichikawa, T., Kamai, T., Kaji, Y., Kume, H., Kondo, T., Matsuyama, H., Masumori, N., Kawauchi, A., Takenaka, A., Uemura, H., Eto, M., Nonomura, N., Fujii, Y., …, & Ohyama, C. (2024). Summary of the Clinical Practice Guidelines for Upper Tract Urothelial Carcinoma 2023 by the Japanese Urological Association. International Journal of Urology, 31(3), 194-207. https://doi.org/10.1111/iju.15362

Vancouver

Mori K, Hatakeyama S, Enokida H, Miyake H, Kikuchi E, Nishiyama H, et al. Summary of the Clinical Practice Guidelines for Upper Tract Urothelial Carcinoma 2023 by the Japanese Urological Association. International Journal of Urology. 2024;31(3):194-207. doi:10.1111/iju.15362

BibTeX
@article{Mori2024,
  author = {Mori, Kazuyuki and Hatakeyama, Shingo and Enokida, Hideki and Miyake, Hideaki and Kikuchi, Eiji and Nishiyama, Hiroyuki and Ichikawa, Tomohiko and Kamai, Takao and Kaji, Yasushi and Kume, Haruki and Kondo, Tsunenori and Matsuyama, Hideyasu and Masumori, Naoya and Kawauchi, Akihiro and Takenaka, Atsushi and Uemura, Hirotsugu and Eto, Masatoshi and Nonomura, Norio and Fujii, Yasuhisa and Hinotsu, Shiro and Ohyama, Chikara},
  title = {Summary of the Clinical Practice Guidelines for Upper Tract Urothelial Carcinoma 2023 by the Japanese Urological Association},
  journal = {International Journal of Urology},
  year = {2024},
  volume = {31},
  number = {3},
  pages = {194--207},
  doi = {10.1111/iju.15362}
}
Kostenlos starten →